Prof dr Karel Allegaert, MD, PhD is pediatrician-neonatologist and clinical pharmacologist. He is associate Professor at KU Leuven (2016-2018, 20%) and Consultant at MC Rotterdam (2016-2018, 80%). He is president of the European Society for Developmental Pharmacology and is former Board Member of the European Society for Pediatric Research (section clinical pharmacology). Specific interests in the fields of perinatal clinical pharmacology and neonatal intensive care.
Ola Andersson, MD, PhD is board certified in Paediatrics and Neonatology. His is working as a consultant at the Paediatrics department at Hospital of Halland, where he also holds a position as medical director at the Research and Development department. He is affiliated to Uppsala University and have conducted to randomised controlled trials on term infants and umbilical cord clamping in Sweden and Nepal. Presently, he is PI for a study on bedside resuscitation without cord clamping in Nepal.
Anna Axelin, RN, PhD, Adjunct Professor is the Director for Separation and Closeness Experiences in the Neonatal Environment (SCENE) research group and a University Research Fellow in the Department of Nursing Science at the University of Turku, Finland. Her academic career has included conducting quantitative and qualitative research in multidisciplinary research groups. Her main research interest is family centered care in neonatal context.
Olga Basso is Associate Professor of epidemiology at McGill University (Canada) since 2010. Educated in Pavia, Italy, she has worked at the Danish Epidemiology Science Centre (Denmark) and the National Institutes of Environmental Health Sciences (USA). Her research focuses on the methodologic and substantive aspects of studying complex determinants, such as preterm birth and infertility, in reproductive epidemiology.
I am an early-stage clinician-scientist, trained in one of the French MD-PhD programs, graduating in chemistry and anaesthesiology/intensive care. I have a special interest in neonatal and paediatric anaesthesia and intensive care. I use spectroscopic approaches, such as nuclear magnetic resonance and mass spectrometry, to decipher metabolic changes that can be connected to various pathophysiological conditions.
Geraldine Boylan is Professor of Neonatal Physiology, Department of Paediatrics & Child Health, University College Cork, Ireland and Director of the Irish Centre for Fetal and Neonatal Translational Research – INFANT www.infantcentre.ie
Geraldine has worked in the area of clinical neurophysiology for many years and since 1996 has worked exclusively in the field of neonatal neurophysiology.
She leads the Neonatal Brain Research Group at the INFANT centre – a multidisciplinary research team focused on neurological monitoring of infants in the neonatal intensive care unit, particularly for seizure detection and the early diagnosis of brain injury. Researchers in the team develop automated algorithms for monitoring newborn brain activity and monitoring tools for physiological data acquisition. They developed a novel seizure detection algorithm for newborn infants which was recently evaluated in a Wellcome Trust funded clinical trial across 8 centres in Europe www.anserstudy.com.
Department of Neonatology, La Paz University Hospital, Spain
Dr. Marsha Campbell-Yeo is a certified neonatal nurse practitioner, an Associate Professor at Dalhousie University School of Nursing, and a Clinician Scientist at the IWK Heath Centre with cross appointments to the Departments of Pediatrics, and Psychology and Neuroscience. She maintains .2 in the NICU in the role of a neonatal nurse practitioner. Her research lab, primarily funded by the Canadian Institute of Health Research and Canadian Foundation of Innovation Grant, entitled “Mechanisms, Outcomes, and Mobilization of maternally-Led Interventions for Newborn Care” (MOM-LINC), provides an interdisciplinary research environment for the development of innovative and non-invasive healthcare interventions that engage mothers and families in the management and care of neonates.
She currently holds a Canadian Institute of Health Research (CIHR) New Investigator Award (2017-2021), an Career Development Award from the Canadian Child Health Clinician Scientist Program Award (2015-2019) and she has been the recipient of the Canadian Pain Society Early Career Award (2015), Excellence in Nursing Research Award (2014);, College of Registered Nurses of Nova Scotia (2014); Global Health REAL Award (2013); and CIHR fellowship (2008-2012). She is a mentor in the Pain in Child Health (PICH) training program.
Dr. Campbell-Yeo is the Secretary on the Board of Directors for the Canadian Pain Society (2014-2017), and is an elected Council Member for the IASP Special Interest Group on Pain in Childhood (2015-2020). Dr. Campbell-Yeo is a Mayday Pain and Society Fellow.
Research Associate Professor of Pediatrics, Director, Neonatal Pulmonary Research Laboratory, Division of Neonatology, Department of Pediatrics, University of Miami Miller School of Medicine
I am a neonatal nurse practitioner. Besides clinical work I focus mainly on the Case Management for the extreme premature born children and the development of involving parents in direct care.
Dr Peter Davis is the Professor/Director of Neonatal Medicine at The Royal Women’s Hospital, Melbourne. He has led the Department of Newborn Research since 2009.
He completed his MBBS at the University of Queensland in 1982 and underwent basic paediatric training in Brisbane. He completed his neonatal fellowship training at McMaster University, Canada where he developed an interest in Clinical Epidemiology and Evidence Based Medicine. After returning to Australia in 1993, he was appointed as a consultant neonatologist at The Royal Woman’s Hospital, Melbourne. His interest in non-invasive ventilation led to an MD through the University of Melbourne in 1998. He leads a young team of enthusiastic clinical researchers interested in improving the care of babies in the delivery room and in the intensive care unit. He is a substantial contributor to the Cochrane Collaboration and a member of the neonatal subcommittee of the International Liaison Committee on Resuscitation (ILCOR). Support for his research comes from the Australian National Health and Medical Research Council through a Practitioner Fellowship, a Program Grant and a Centre for Research Excellence Grant. Other project support comes from the Australian government and NIH, Dr Davis has more than 300 peer reviewed publications and is on the editorial board of three international journals.
Willem de Boode obtained his medical degree at the Free University of Amsterdam in the Netherlands. Since 1999 he is member of staff of the Department of Neonatology of the Radboudumc Amalia Children’s Hospital in Nijmegen, The Netherlands, where he was trained in Paediatrics and Neonatology. His areas of interest are neonatal haemodynamics, extracorporeal life support, acid-base balance (Stewart approach), neonatal surgery, and neonatal intensive care transport.
The focus of his research is on Advanced Haemodynamic Monitoring. He is involved in both experimental and clinical research. In 2010 he defended his thesis, entitled “Neonatal hemodynamic monitoring. Validation in an experimental animal model”.
Willem de Boode is founder and chairman of the “Dutch Working Group on Neonatal Haemodynamics”, council member of the European Society for Paediatric Research (ESPR) and secretary of the Section “Circulation, Oxygen Transport and Haematology” of the ESPR.
Willem is chairing the ESPR/ESN special interest group “Neonatologist Performed Echocardiography”, that is formulating European guidelines regarding the use of echocardiography on the NICU. He is the project leader of the BeNeDuctus Trial, an international multi-center, randomized non-inferiority trial of early treatment versus expectative management of patent ductus arteriosus in preterm infants, that is funded by The Netherlands Organization for Health Research and Development (ZonMw) – ClinicalTrials.gov Identifier: NCT02884219.
Willem de Boode is happily married and father of 4 children. His hobbies are drumming, boat building and theatre.
Prof. Daniele De Luca received his MD license from the Catholic University of the Sacred Heart in Rome, Italy in 2001. Prof. De Luca completed his Master’s degrees at the same university in Paediatric Emergencies in 2003 and Neonatal Pulmonology in 2005. He received a Fellowship in Paediatrics and Neonatal Critical Care from the same university in 2007. He is now the Medical Director of the Division of Paediatrics and Neonatal Critical Care and Associate Professor of Neonatology at South Paris University, “A.Beclere” Medical Centre, in Paris, France. He is also the Contract Professor of Neonatal and Paediatric Critical Care Catholic University of the Sacred Heart in Rome, Italy.
Prof De Luca has published approximately 150 papers for journals with an impact factor > 300, an H-Index of 18, and has been a referee for several major paediatric and general journals. He has been a referee for international grants and research quality programs in EU, Germany, Netherlands, UK, Canada, France, Italy, and South Africa. Dr De Luca is the Secretary of the European Society for Paediatric and Neonatal Intensive Care (ESPNIC) and Council member of the European Society for Pediatric Research (ESPR).
Professor Dempsey is a Science Foundation Ireland Principal Investigator within INFANT.
He has significant experience in conducting newborn clinical trials. His principle area of interest is cardiovascular support in the preterm infant. He is the lead PI for a number of on-going SFI funded studies including Neuroprobe, a study addressing the relationship between blood pressure and cerebral activity in preterm infants.Other areas of interest include ethical issues pertaining to the newborn infant, manual ventilation, newborn resuscitation training, simulation based procedural healthcare, enhanced newborn stabilization, cerebral oxygenation and the role of NIRS in delivery suite management. He has acted as an international reviewer for a number of funding agencies including the NIHR and the European Commission.
Ferdinando Di Cunto is Professor of Molecular Biology at the University of Torino. He is member of the Italian Society of Biophisics and Molecular Biology (SIBBM), of the Italian Society of Neuroscience (SINS), of the Italian Cosiety of Biochemistry (SIB), of the Italian Society of Bioinformatics (BITS), and of the American Society of Cell Biology (ASCB). Since many years he has developed his research activity in both the experimental and computational biology fields. In the first field, he has been mainly studying the role of cytoskeletal control pathways in the proliferation and in the differentiation of mammalian neuronal precursors, with a specific focus on the involvement of these mechanisms in microcephaly. In the second field, he has concentrated on the development of computational methods for integrative genomics and systems biology. His research activity has been supported by MURST/MIUR, Telethon Foundation, University of Torino, San Paolo Bank Foundation, Piedmont Region, Fondation Jèrome Lejeune, Italian Ministry of Health, Cavalieri Ottolenghi Foundation and lately by Italian Association for Cancer Research (AIRC). FDC serves as peer reviewer for several prestigious scientific Journals and is Associate Editor of PLoS-ONE.
Jon is a neonatologist and academic who as chief and local investigator has been involved in many neonatal trials. Amongst other studies, he has led the SIFT team studying the optimal speed of increasing milk feeds in preterm infants.
Professor Doyle is a neonatal paediatrician with a major research interest in evaluating the consequences of neonatal intensive care, including how to improve on that care, and its economic consequences. He has been a chief investigator on numerous randomised controlled trials of interventions before and after birth designed to improve the outcome for the highest-risk babies, including the tiniest and most immature babies. He is active with several research groups interested in the outcome for tiny babies well beyond the nursery and into adulthood; these are the Premature Infant Follow-up Programme at the Royal Women’s Hospital, the Victorian Infant Collaborative Study (VICS) Group, and the Victoria Infant Brain Studies (VIBeS) Group.
Jessica Dubois is a INSERM researcher in the Cognitive Neuroimaging Unit (U992, CEA/NeuroSpin, France), with a background in Physics and Neurosciences. Her works are focused on the early development of the brain studied with neuroimaging (MRI and EEG) in newborns and infants.
Afif graduated from Trinity College, Dublin in 2002 and enrolled in the Royal College of Physicians of Ireland paediatric specialist training scheme in 2005. He completed a Doctor of Medicine (MD) degree in University College, Dublin in 2008 and his neonatal specialty training in Toronto, Canada (2009-2011). Following this, he was appointed as a consultant Neonatologist and Assistant Professor of paediatrics at the University of Toronto in January of 2011. He obtained diploma in clinical epidemiology during his time in Toronto. Afif explored the use of novel technology in monitoring the haemodynamic status of preterm infants and was part of the only neonatal echo training course in Canada. He co-devised the world’s first echo teaching website and mobile device application. Recently, Afif have assumed a leadership role at a European level in devising training guidelines for echocardiography by the Neonatologist. In addition, he is the lead editor of the Haemodynamic Module in the NOTE project which offers a new international online Masters (M) level educational programme in neonatal medicine as collaboration between the European Society for Neonatology (ESN) and the Faculty of Health Sciences at the University of Southampton.
Trained in UK with time in Nottingham and Oxford. Moved to Australia in 1991 and since then have been Staff Specialist in Newborn Care at Royal Prince Alfred Hospital and Clinical Associate Professor at University of Sydney. Main interest in training and for use of ultrasound in acute neonatal care and neonatal haemodynamics.
Anders Fasth, MD, PhD, is Professor of Pediatric Immunology at University of Gothenburg, Gothenburg, Sweden. He established the Hematopoietic Stem Cell Transplantation Program at the Queen Silvia Children’s Hospital, Gothenburg as a treatment for immunodeficiencies, leukemias and other blood disorders and acted as its Medical Director since the start in 1984 and until 2011. He is also Medical Director of the Swedish National Cord Blood Bank at Sahlgrenska University Hospital, Gothenburg and Consultant Immunologist at the National Children’s Hospital, San José, Costa Rica since 1985. His main research interest lies in primary immunodeficiencies and pediatric rheumatology.
Dr Fasth earned his MD and PhD at the University of Gothenburg. He has also completed clinical and research fellowship at UCLA, CA, USA and at Hospital for Sick Children at Great Ormond Street, London, UK. He has authored or coauthored more than 230 scientific articles plus several textbook chapters. Dr Fasth has also served as chairperson of the Educational Working Committee of ESID and is a board member of the Swedish Primary Immunodeficiency Association.
After graduation as a general nurse in 1986 Odile has been graduated for several nursing applications. Since 1993 Odile has been employed at the neonatology intensive care ward in the Sophia Children’s Hospital Erasmus MC Rotterdam.
In 2003 Odile graduated as a Master in Advanced Nursing Practice and she has been working as a neonatal nurse-practitioner since then.
Beside her clinical work Odile is the Vice president of the registration committee for Dutch nurse practitioners (verpleegkundig specialisten, RSV), a member of the scientific advisory board of the European Foundation for the Care of the Newborn infants (EFCNI), past president (2006-2015) of the Dutch association for nurse practitioners (V&VN VS), past nursing president of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC)
Odile is an editorial board member of the online magazine Treatment In Paediatrics, member of the advisory board of the registration committe for Dutch Dentists and a member of the accreditation teams for the NVAO/RSV in 2014/2015.
In the past she participated in the commissions for the Dutch ministry of Health to advise in the legislation for nurse practitioners in the Netherlands. She was involved in the introduction of independent nurse prescribing in the Netherlands in 2012.
Since october 2013 she is one the knowledge ambassadors of the city of Rotterdam.
In September 2016 she goes back to school as a student MSc in quality and patient safety at the Radboud University in Nijmegen
Vivette Glover is Professor of Perinatal Psychobiology at Imperial College London. Her research has shown the effects of the emotional state of the mother during pregmnancy, both on the developing fetus and longer term on the child, and the biological mechanisms that may underlie such fetal programming. She has published over 400 papers. She has been an advisor to the Department of Health, the Early Intervention Foundation, the NSPCC, Best Beginnings and the biometric lead for A Better Start. Her work is contributing to changes in policy, with a growing awareness that better emotional care for women in pregnancy can improve the outcome for the next generation.
Professor Stuart Hooper is a NHMRC Principal Research Fellow and Director of the Ritchie Centre, Hudson Institute for Medical Research and Director of Research for the Department of Obstetrics and Gynaecology, Monash University. He is a fetal and neonatal physiologist whose research focuses on fetal and neonatal lung development and its transformation into a functional gas-exchange organ at birth. His research focuses on; (1) factors regulating lung growth, (2) the cardiovascular and respiratory transition at birth and (3) how respiratory support of very preterm infants can be improved to facilitate their transition at birth.
Prof. Petra Hüppi, is a clinician in pediatrics. Since 1998 she runs the Child Development Unit and the Division of Development and Growth at the Department of Pediatrics, Geneva University Hospitals, Switzerland. She received her MD from the University of Berne, where she trained in pediatrics, and newborn medicine at the Joint program in neonatology at Childrens Hospital, Harvard medical School, Boston.
Next to her clinical work, she is a full professor at the University of Geneva and has international research activities with a visiting scientist position at Harvard Medical School in Boston, USA. She has directed numerous research projects both at Harvard Medical School and the University of Geneva, aimed at the better understanding of early human brain development. Her research has helped in a major way to understand the specific brain deficits found in prematurely born children, highly relevant for the cognitive and socio-emotional development of children and adolescents.
Her international status is further documented through her various commitments in major scientific societies and organizations. She serves as a Board of Trustee member of the International Society for Magnetic Resonance in Medicine (ISMRM) and the International Pediatric Resarch Foundation (IPRF) and is an elected member of the National Research Council of both Switzerland and France.
In order to join forces to study scientifically both the care and medical interventions on children’s long-term development, she founded the European association for developmental care (EADCare:http://www.eadcare.org/site/fr/contact)
Silvia Iacobelli, MD, PhD, full Professor of Pediatrics
Silvia Iacobelli is head of the NICU-PICU-neonatology department and medical coordinator of the Délégation à la Recherche Clinique et à l’Innovation at La Réunion University Hospital in St. Pierre, France. She is also a clinical research physician at the Centre d’Etudes Périnatales de l’Océan Indien (EA 7388) at the Université de La Réunion. Professor Iacobelli received her medical degree from the Bari School of Medicine in Apulia, Italy. Subsequently, she completed residencies in paediatrics at both Bari University Hospital and the Université de Strasbourg, France. In 2013, she earned a PhD in epidemiology and public health from the Université de Bourgogne, France and became full Professor of Pediatrics in 2017. Her clinical interests include neonatal intensive care medicine, extremely low birth weight infant care, renal function in preterm babies, parenteral nutrition in newborn infants, and perinatal epidemiology, and her research has been published in numerous medical journals, including Neonatology, PLoS One, BMC Paediatrics, and the Journal of Clinical Pharmacology and Therapeutics. Additionally, she has authored or co-authored several book chapters and clinical reports. Board certified in paediatrics by the Bari School of Medicine, Professor Iacobelli is a member of the French Society of Neonatology, the French Society of Paediatrics, the Société Francaise de Pédiatrie de l’Océan Indien, a member of the Nutrition, Gastroenterology and Metabolism Council of ESPR, and 2015 expert working group (ESPGHAN, ESPEN and ESPR) to update the paediatric parenteral nutrition guidelines.
Dr Mark Johnson is a Consultant and Honorary Senior Lecturer in Neonatal Medicine at University Hospital Southampton NHS Foundation Trust. He has an active research programme at the NIHR Southampton Biomedical Research Centre in nutrition, which centres around the nutritional care and growth of preterm infants, nutritional assessment and the implementation of practice change in order to improve care. His work has also included the development of a neonatal nutritional screening tool and neonatal nutritional assessment. He has also undertaken several systematic reviews looking at the use of early parenteral nutrition in preterm infants, the impact of enhanced nutrition on the neurodevelopmental outcomes of preterm infants, and the effect of preterm birth on body composition and growth. He was successful in gaining a prestigious NIHR Doctoral Research Fellowship to fund his PhD in 2012, is a member of the BAPM working groups on parenteral nutrition and research skills training, and the ESPR Nutrition Section. Mark is also currently the lead for education and training for nutrition in the NIHR Southampton Biomedical Research Centre.
Dr. Sandra Juul completed her MD, residency, and fellowship at the University of Washington. To make further contributions to the field of Neonatology, she pursued and completed her Ph.D at the University of Chicago. Dr. Juul’s research focuses on the neurodevelopment and neuroprotection of at-risk newborns, primarily extremely preterm infants, and term infants with hypoxic ischemic encephalopathy, since both groups have outcomes of approximately 50% death or severe neurodevelopmental impairment. Her research lab includes basic science and translational studies in multiple animal models, including rodents, ferrets and nonhuman primates. She is the principal investigator for the Preterm Epo Neuroprotection Trial (PENUT) and co-PI of HEAL (High dose Epo for asphyxia and encephalopathy).
Gillian Kennedy is Consultant Speech and Language Therapist for Neonates /Paediatrics at UCLH and is one of two NIDCAP Trainers in the UK.
She undertook her undergraduate training in Edinburgh and developed a particular interest in swallowing, leading to her studying for an MSc at City University.
Following several years working with adults in both neurological and neuro-surgical settings, she brought many of the skills and knowledge gained in this clinical area to her work with preterm infants and high risk neonates and young children with neurological involvement. Over the past 25 years she has worked exclusively with premature infants and high risk neonates and their families.
Her work in supporting babies and their families in establishing feeding has been enhanced by her NIDCAP Training. Currently, she has particular interest in promoting comfortable digestion during tube feeding to facilitate the baby’s transfer to oral feeding.
Gillian progressed to becoming a NIDCAP Trainer and works collaboratively with Inga Warren, Senior Trainer at the UK NIDCAP Centre. She is a national advisor for therapies and regularly teaches both nationally and internationally.
She was appointed OBE in June 2015 for her work.
Dr Elsa Kermorvant is Associate Professor in Pediatrics at Paris Descartes University and serves as attending neonatologist in the NICU of Necker-Enfants malades Hospital in Paris. She holds a PhD degree from Paris Descartes University.
Her special clinical interests include neonatal nutrition and congenital malformations. Her basic science research activities have been focusing on perinatal factors that influence retinal development and retinopathy of prematurity since her postdoctoral fellowship in the Department of Pediatrics, Ophthalmology and Pharmacology, Saint-Justine Hospital Research Center in Montreal, Canada, under the direction of Prof. Sylvain Chemtob. Her current work is centered specifically on the consequences of neonatal hyperglycemia on the developing retina.
She is also very active in the field of medical education, especially in simulation-based education in the Simulation Center of Paris Descartes University.
She is a member of the Board of the French Society of Neonatology (SFN).
Kai König trained in Hamburg and Berlin, Germany, in general paediatrics and paediatric intensive care, before relocating to Melbourne, Australia, in 2006, where he completed his neonatal training and worked as a consultant neonatologist at the Mercy Hospital for Women und the Royal Children’s Hospital between 2008 and 2013. In 2013, he continued working as a consultant neonatologist and paediatric intensivist at the Children’s Hospital Lucerne, in Switzerland, before moving into primary care paediatrics in 2016. He is one of three paediatricians in a busy paediatric practice in the centre of Lucerne, Switzerland. Having worked on both sides of neonatal care, he is very much interested in improving the transition of high-risk newborns from their stay in the neonatal intensive care unit into the primary care setting.
Pierre Kuhn is a senior neonatologist, Professor of pediatrics and head of the Neonatal Intensive Care Unit at the University Hospital of Strasbourg (France). His research focusses on the sensory sensitivities of preterm infants, on the evaluation of the impact of the hospital environment on brain development and of developmental care strategies. His PhD in Neuroscience focussed on the auditory sensitivity of preterm infants. He has spent one full year in Stockholm at the Karolinska Institute (KI) as an invited researcher and still collaborates with the neonatal research unit of Astrid Lindgren Hospital at KI. He is also the co-founder and co-coordinator of the Group of Reflection and Evaluation of the Environment of Newborns of the French Neonatal Society (GREEN de la SFN). He is the co-chair of the Topic Expert Group on “Infant and family centred developmentally supportive care” of the European foundation of the Care of Newborn Infants.
Beatrice Latal MD MPH Dr. Latal is the Co-Director of the Child Development Center at the University Children’s Hospital Zurich. She leads a large research group and is dedicated to teaching and faculty development.
In her research, she investigates the developmental outcome of newborns and children at risk for neurodevelopmental disorders. This includes children born very prematurely, children with hypoxic-ischemic encephalopathy (“perinatal asphyxia”) and children with severe congenital heart disease. Dr. Latal’s main research goals are to characterize the prevalence and severity of neurodevelopmental impairments in these children, to identify the potential risk factors for impairments and to study the mechanisms involved in the etiology of brain injury. Dr. Latal also examines the application of diagnostic tools such as amplitude integrated EEG, cerebral MRI and neurological examination for their potential usefulness as outcome predictors. Outcome research is becoming more important with the increasing survival rates achieved thanks to major improvements in intensive care medicine and general care. A better understanding of the mechanisms involved in the etiology of brain injury in these high-risk children will allow for neuroprotective drug therapies and other interventions. Such interventions will improve the neurodevelopmental outcome and quality of life of these vulnerable patients and will ensure an optimal integration into adult life.
Prof. dr. Jos Latour is Professor in Clinical Nursing at Plymouth University in Plymouth, UK. His clinical post is based at Derriford Hospital in Plymouth and Musgrove Park Hospital in Taunton in the UK where he is the director of the Clinical Schools aiming to drive clinical research and trials. The research lines of Prof Latour are family involvement in care and clinical trials, patient and family centred care, end-of-life care practices, and paediatric sepsis. He is an associate-editor of Pediatric Critical Care Medicine and editorial board member of several other international peer-reviewed journals.
Dr. Shoo Lee is a neonatologist and health economist. He is Scientific Director of the Institute of Human Development, Child and Youth Health (IHDCYH) at the Canadian Institutes of Health Research; Professor of Paediatrics, Obstetrics & Gynaecology and Public Health; Paediatrician-in-Chief and Director of the Maternal-Infant Care (MICare) Research Centre at Mt. Sinai Hospital and Senior Clinician Scientist of the Lunenfeld-Tannenbaum Research Institute.
Dr. Lee received his medical degree from the University of Singapore, completed his paediatric training at the Janeway Children’s Hospital in Newfoundland and neonatal fellowship training at Boston’s Children’s Hospital, and received his PhD in Health Policy (Economics) from Harvard University.
As the founder and Chairman of the Canadian Neonatal NetworkTM and the International Neonatal Collaboration, Dr Lee fosters collaborative research, and he leads the CIHR Team in Maternal-Infant Care. His research focuses on improving quality of care, patient outcomes and health care services delivery. He developed Family Integrated Care model and piloted the concept at Mount Sinai Hospital.
Awards for his work include the CAPHC 2016 Contribution to Child Health Award, SPR Douglas K. Richardson Award for Perinatal & Pediatric Healthcare Research, CIHR Knowledge Translation Award, the Aventis Pasteur Research Award and the Distinguished Neonatologist Award from the Canadian Paediatric Society, the Premier Member of Honour Award from the Sociedad Iberoamericana de Neonatologia, Magnolia Award from the Shanghai government and Honorary President of the Xiamen Children’s Hospital from the Xiamen government.
Professor Liisa Lehtonen leads the Division of Neonatology at Turku University Hospital which granted the status of Center of Excellence. Her research focuses on developing the neonatal care to optimize the outcome of preterm infants. She has developed family centered care and is one the developers of the Close Collaboration with Parents training program.
Petra Lemmers was graduated in medical science at Leiden University in the Netherlands (cum laude) and was trained in pediatrics at the Sophia Children’s Hospital/Erasmus University Hospital Rotterdam (NL) and in neonatal medicine in the Isala Clinics Zwolle (NL) and the Wilhelmina Children’s Hospital/University Medical Center Utrecht (NL).
At the present time she is associate professor in neonatology (research school Child Health, University Medical Center Utrecht), she is working as an expert of the customer excellence program ‘Samen voor de Patient’ in the University Medical Center Utrecht and as a consultant neonatologist at the NICU of the Wilhelmina Children’s Hospital Utrecht. The main focus of research on this NICU is the neonatal brain: brain monitoring, brain hemodynamics, neuroprotection, brain imaging and neurodevelopmental outcome (prof Manon Benders and prof Linda de Vries). In 2003 she started her research concerning the clinical use of non-invasive cerebral monitoring by near infrared spectroscopy (NIRS) in (preterm) neonates admitted on the NICU. She defended her thesis “The clinical use of near infrared spectroscopy‐monitored cerebral oxygen saturation and extraction in the preterm infant” in 2010 and published until now > 60 peer reviewed papers about this subject in prominent scientific journals.
Nowadays on the NICU the brain of preterm infants, neonates after perinatal asphyxia and all infants undergoing surgery in the neonatal period are monitored by NIRS during the most vulnerable period after birth: during transition, during treatment with hypothermia, but also during surgery.
She also participates in national and international collaborative projects concerning NIRS (SafeBoosc-trial: prof Gorm Greisen Kopenhagen Denmark; TOHOP-trail/cerebral hemodynamics: prof Istvan Seri Los Angeles USA, currently Doha Quatar; NIRS-project concerning monitoring cerebral autoregulatory ability: prof Gunnar Naulaers and prof Sabine van Huffel Leuven, Belgium. She is supervising several PhD students and is involved in education and training programs concerning brain monitoring in neonates in the Netherlands and abroad.
Silke Mader is the Chairwoman of the Executive Board and co-founder of EFCNI. In 1997, her twins were born in the 25th week of pregnancy, and were not given the appropriate care. Unfortunately, one of them died a few days after birth, leaving the parents and the sibling behind. During her time in hospital and afterwards, she was faced with the non-existence of support of any kind, the absence of public awareness and the lack of information and education for parents during pregnancy. She felt that no parents should ever undergo such an awful experience again.
Silke Mader is author, co-editor and technical editor of reports and publications on the situation of preterm birth and newborn health in Europe and beyond.
In 2012 Silke Mader was awarded the “Prix Courage” in Germany. 2013 she received the Medal for Particular Services to Bavaria in a United Europe. Since 2014 she is Honorary Lecturer at the School of Nursing and Midwifery, Queen’s University Belfast, Northern Ireland. In 2015, Silke Mader has been awarded as social entrepreneur and Ashoka Fellow. At the ALL Ladies League (ALL) – Women Economic Forum 2016 in New Delhi, India, Silke Mader received the “Iconic Innovative Trailblazer of the Decade” award. During an official ceremony in Nuremberg on 14 October 2016, Silke Mader was awarded with the Bavarian State Medal for Services concerning Health and Long-term Care by Melanie Huml, the Bavarian State Minister for Health and Long-term Care.
Patrick McNamara graduated from Queens University Belfast in 1987, received his MRCPCH in Pediatrics in 1997 and Certificate of Completion of Specialist Training in Neonatal Medicine in 2002. He is currently a Staff Neonatologist and Director of Clinical Research within the Division of Neonatology at the Hospital for Sick Children, and Professor of Pediatrics and Physiology, University of Toronto. He is the chair of the Canadian Targeted Neonatal Echocardiography working group and the Chair of the Canadian Neonatal Resuscitation Program. He is the current chair of the International Paediatric Academic Society Neonatal Hemodynamics Collaborative. His clinical and research interests include myocardial performance in the settings of a hemodynamically significant ductus arteriosus, pulmonary hypertension and targeted neonatal echocardiography.
Dr. Miller is Head of the Division of Neurology and Centre for Brain and Mental Health at SickKids. He is a Senior Scientist in Neurosciences & Mental Health program in the SickKids Research Institute. He is a Professor in the Department of Paediatrics at the University of Toronto and holds the Bloorview Children’s Hospital Foundation Chair in Paediatric Neuroscience.
Collaborating with a multidisciplinary team, Dr. Miller’s research program focuses on better understanding brain injury and development in the newborn. He and his team use advanced brain imaging and detailed long-term follow-up to help children who were born early or with conditions that put them at risk of neurological and developmental deficits. He has contributed to our understanding of brain abnormalities caused directly by premature birth, perinatal asphyxia or indirectly by congenital heart disease.
Professor of Neonatal Medicine at Imperial College London, Consultant at Chelsea and Westminster Hospital, and President of the UK Royal College of Paediatrics and Child Health.
Neena leads a neonatal research programme focused on the perinatal determinants of life-long health. She led the development of the UK National Neonatal Research Database, an internationally unique “big-data” resource on all admissions to neonatal units in England, Wales and Scotland, used for a wide range of national and international research, quality improvement, audit, and surveillance outputs. Neena is extensively published in peer-reviewed journals, has authored a number of chapters in textbooks, commentaries and reviews, and directs the well-known “Neonatal Update: The Science of Newborn Care”, a week-long international academic meeting held in London each December.
Neena has made many contributions to children’s services. She has been at the forefront of reinvigorating the clinical research base of paediatrics and child health, and has championed opportunity for research experience for all paediatricians. She has served on many working parties and committees, and has held a large number of national roles including President of the UK Neonatal Society, President of the Academic Paediatrics Association of Great Britain and Ireland, Chair of the British Medical Journal Ethics Committee, and Chair of the NHS England Infant, Children and Young People Patient Safety Expert Group.
Dr Colin Morgan began his longstanding interest in neonatal nutrition by studying neonatal long chain polyunsaturated fatty acid absorption in preterm and term infants. In 1999, he became Senior Lecturer in Neonatal Medicine at University College London (Royal Free Hospital) and moved to the Liverpool Women’s Hospital as Consultant Neonatologist in 2004. He is a regular contributor to educational packages explaining the scientific rationale for early enteral and parenteral nutritional strategies in term and preterm infants. He also has a particular interest in postgraduate medical education and advanced nursing practice. He is currently Head of School (Paediatrics) for Health Education England North West. His current research interests focus on neonatal parenteral nutrition formulations and the impact of early neonatal nutrition on postnatal metabolic adaptation, brain growth and neurodevelopment outcome in very preterm infants. He is also actively involved in a number of projects improving the quality and safety of early nutritional interventions in neonatal clinical practice including the use of standardised parenteral nutrition and donor breast milk.
Dr Deirdre Murray graduated from UCC in 1995 and trained in Paediatrics in Dublin, before specialising Paediatric Intensive Care in leading International Paediatric Hospitals: the Royal Bristol Children’s Hospital and the Royal Children’s Hospital in Melbourne, Australia. She returned to Ireland to persue a dedicated research post and completed the first PhD in the Department of Paediatrics, UCC in June 2008. This thesis focussed on early continuous EEG in neonatal brain injury.
She took up her post as Senior Lecturer in the Department of Paediatrics and Child Health in 2008 and has developed her research interest into early brain injury and neurodevelopmental outcome since that time. Her aim is to improve long term neurological outcome through improved detection, prediction and early intervention following neonatal brain injury. Dr Murray is the Principal investigator of the Cork BASELINE Birth Cohort Study and through this study, funded by the National Children’s Research Centre has established a large extremely well phenotyped birth cohort with the first neonatal biobank in Ireland. In 2012 she was the first Irish Paediatrician to be awarded the prestigious HRB Clinician Scientist Award to develop her research in the field of novel biomarkers in Hypoxic-Ischaemic Encephalopathy through the BiHiVE study. In 2013 she became one of 9 Principal Investigators in the Irish Centre for Fetal and Neonatal Translational Research (INFANT centre).
Current positions:Current positions:• Consultant in charge of paediatric cardiology and consultant in neonatology at Dept. of Paediatrics, Vestfold Hospital Trust, Tønsberg, Norway • Postdoctoral researcher at the Center for Cardiological Innovation, Oslo University Hospital and the University of Oslo (http://www.heart-sfi.no/)Education:• Philosophia doctor, University of Oslo 2010 (Thesis: “Longitudinal strain and strain rate by tissue Doppler in term neonates”)• Specialization in Paediatrics and Neonatology 2005• MD University of Oslo, 1997
Board memberships:• Section board member of the “Circulation, Oxygen Transport and Haematology” section in the European Society for Paediatric Research • Section board member of the Working Group of Echocardiography in the Norwegian Society of Cardiology [Norsk Cardiologisk Selskap]Academic interests: • I have in PhD- and postdoc-positions since 2005 done research in cardiology and neonatology with focus on the interplay between newborn circulation and heart function, especially the transitional phase from fetal to newborn circulation and assessment of heart function by ultrasound in healthy and sick newborns. I have put down much effort in improving the methods used for assessing myocardial function by ultrasound, including a patent pending (“Choosing variables in tissue velocity imaging”) and several papers. • In my current research position at the Center for Cardiological Innovation, my main research topics in adult cardiology are on developing new echocardiographic methods for identification of myocardial scars. Further, I participate in the SysAFib-project, an EU-project aiming at developing novel diagnostic tools by use of machine learning (advanced computer modelling, “big data”) for treatment of patients with atrial fibrillation.Research group, supervising tasks, and international contacts and cooperation: I am a senior member of the research group NeoCHIBS (Neonatal Circulation, Heart, Infection and Brain Study Group) at the Oslo University Hospital/University of Oslo, led by Professor Drude Fugelseth. NeoCHIBS is an internationally leading group on echocardiographic assessment of heart function in neonates, with national and international collaborators. Within the group, I am principal supervisor in a PhD project on functional echocardiography in intra-uterine growth restriction, “The transition at birth of hepatic, cardiac and cerebral circulation, blood flow distribution, and myocardial function in term and preterm infants with intrauterine growth restriction”. PhD-candidate is MD Lisa Bjarkø. I have acted as a co-supervisor in one PhD project in functional echocardiography and as a co-worker in a second PhD project in functional echocardiography within the group. November 2016, one group member (MD, PhD Sissel Moltu) received a 12M NOK grant from The Research Council of Norwegian for a project on nutrition in premature neonate (the IMNuT trial). Part of the project will focus on short- and long-term heart function outcome, as a PhD project where I will act as principal supervisor. The group is also the Norwegian collaborator in the ALBINO project (http://cordis.europa.eu/project/rcn/199013_en.html), an EU multicentre trial on treatment of neonates suffering from perinatal asphyxia. Norwegian study coordinator is associated professor Tom Stiris. The primary outcome in the ALBINO trial is survival and neurodevelopmental outcome. We have implemented heart function as a secondary objective in the ALBINO trial, and I will be responsible for the heart function assessment. At Vestfold Hospital Trust, I run the CHOPS trial, studying advanced echocardiography to improve diagnostics in neonates with congenital heart disease. I also administer two epidemiologically based quality health registers in the Vestfold region of Norway, one for children with congenital heart disease and one for neonatal intensive care transportation. I am a member of an international group of 25 researchers in neonatal cardiology and neonatology, (the Special Interest Group for Neonatologist performed Echocardiograph) formed by the European Society for Paediatric Research and The European Society for Neonatology. The group develops guidelines for functional echocardiography in neonatal intensive care.
Other academic merits and qualifications: • Academic co-worker (“faglig medarbeider”) in Paediatrics for the Journal of the Norwegian Medical Association (“Tidsskr Nor Laegefor”)• First author of a novel chapter on functional echocardiography in the upcoming issue of the National Guidelines in Paediatrics (Generell veileder i pediatri) to be finalized in May 2017, issued by the Norwegian Paediatric Association • Referee tasks include the peer review journals Acta Paediatrica, Early Human Development, PLOS ONE, Ultrasound in Medicine and Biology, and Neonatology, and peer reviews of international clinical research fellowships • Experienced computer user with good knowledge in advanced use of computer software (MS Office, SPSS, Sigmaplot, and Adobe). • Master advanced statistics, including mixed models statistics
The Center for Fetal & Neonatal Medicine, Division of Neonatology,
Children’s Hospital Los Angeles, Keck School of Medicine,
University of Southern California, Los Angeles, CA, USA
Julia Petty is a Senior Lecturer in Children’s Nursing at University of Hertfordshire (UH) where she has worked since April 2013. Julia’s role at UH comprises teaching and assessment for a variety of child health modules including leading a module focusing on care of the sick child and a generic nursing module in professional aspects of care. Prior to UH, she worked at City University, London for 12 years where she ran a portfolio of neonatal post-qualifying modules as part of the BSc Nursing programme. She has an extensive educational background in the neonatal specialty including a role of new-born life support instructor for the UK Resuscitation Council. She is link lecturer for a range of children’s and neonatal nursing clinical practice placements. Julia has a keen interest in the development of digital learning resources in neonatal and children’s nursing and has contributed regularly to publications in this as well as other related subjects. She is currently in the early stages of undertaking a Doctorate in Education exploring how a case study approach can be used to understand the patient journey and design specific curricula for learning in neonatal care.
Christian Poets, MD, is Professor of Paediatrics at Tuebingen University. He graduated from Hannover Medical School in June 1986 and received his medical and scientific training at the Dept. of Paediatric Pulmonology & Neonatoloy, Hannover Medical School, Hannover, and at the Dept. of Paediatric Respiratory Physiology, National Heart & Lung Institute, London, UK. In 1994, he became consultant paediatrician, in charge of the Neonatal Intensive Care Unit and the Paediatric Sleep Lab in Hannover, and was appointed Head of the Department of Neonatology at Tuebingen University in 2002. In 2007, he became speaker of the newly founded Centre for Craniofacial Malformations at Tuebingen University Hospital. He also served as president of the Society for Neonatology and Paediatric Intensive Care from 2006-2010. His main research interests lie in the control of breathing, oxygen monitoring, innate immunity, neonatal clinical studies and epidemiology. He is actively involved in large RCTs, e.g. on the effects of inhaled steroids and automated oxygen control, respectively, on neurologically intact survival and BPD prevention in extremely low gestational age infants. He has co-authored >290 articles cited in PubMed and has contributed to over 120 review articles. He is a member of the Neonatal Society (London) and Society of Neonatology & Paediatric Intensive Care (Germany).
Margo Pritchard is Australia’s first appointed Clinical Chair in Neonatal Nursing, a joint position with the Australian Catholic University and Mater Hospitals. She is a Registered nurse, midwife with advanced neonatal nurse training. Her key research areas are addressing screening, surveillance and interventions needs in infants and families cared for in neonatal intensive care units, the importance of the early years and contributing to the evidence base about what works to address these needs. She is well published and has a Research Quality Rating of 5.
Heike Rabe is a Neonatologist working in Brighton, UK. Her research interests are providing extra placental blood to babies at birth, neonatal adaptation and providing age appropriate drugs for newborn babies.
The main focus of my research over the last five years is injury and repair of the pulmonary vascular system. This has included studies into ventilation of newborns with congential lung malformations. From 2008 to 2014, I was principal investigator of a multicentre randomized controlled trial comparing two ventilation strategies in infants with congenital diaphragmatic hernia. We were able to show that initial conventional ventilation might be more beneficial than high-frequency oscillation in these children.
Furthermore, my research included antenatal and postnatal adaptive processes in fetus/newborns with intrauterine growth restriction. We have shown that fetal Doppler patterns are predictive of outcome in severely intrauterine growth restricted infants.
Also, we are studying placental development and the role of the nitric oxide system in normal and abnormal pregnancies. We are establishing an ex-vivo placental perfusion model to study the effects of various pharmacological compounds on placental function with the aim of therapeutic strategies and conducting clinical trials to improve fetal and maternal outcome (in close collaboration with the Departments of Obstetrics and Gynaecology and Vascular Pharmacology).
In the last two years, my research is focusing on the effects of antenatal and postnatal environmental factors on adaptation. This work includes both studies into the effects of oxygen and into the circadian rhythm. We have developed systems that measure and administer optimal oxygen concentrations postnatally. This will lead to a better postnatal management of premature infants. In close collaboration with the Department of Molecular Genetics, we are performing animal studies to examine the effects of social jetlag before and after delivery.
I am a neonatologist and professor of perinatal neuroscience with an interest in brain neuroimaging and neuroprotection. I lead a research group focused on developing a pipeline of safe and effective therapies to augment hypothermic neuroprotection in neonatal encephalopathy. I am interested in neuroprotection that works in all settings across the world and am currently working on Ghana to assess the best strategies to improve outcomes.
I started my research career studying the effects of pain and morphine in preterm infants. Afterwards I did some research on the effects of pain and morphine on the brain in a rat-model. Since then I became interested in neonatal pharmacology in all its aspects. Currently, I am involved in neonatal PK/PD research, dose
finding studies and other clinical trials. Next to that I have a special interest in pharmacological aspects of pregnancy and the placenta.
It is important to realize that pharmacology and drug therapy are involved in almost all fields of
Improved pharmacological knowledge, determination of the correct drug dosages for newborns at different maturational stages, better registration of effects and side-effects would be beneficial for all neonates at the NICU. In the search for new (protective) drug therapies pharmacology is crucial.
Collaboration with the other sections and fields within neonatology is our ambition: Neuroprotection, lungprotection, pharmaco-nutrition and metabolism, better antibiotic dosing, improved knowledge of
circulatory failure and hypotensive treatment, new interventions, etc. Education of basics of
pharmacology and PK/PD is essential for all scientists and clinicians involved in the care of critically ill newborns.
Next to that I am involved in TULIPS. Training Upcoming Leaders in Pediatric Science is a Dutch nonprofit organization that aims to improve the health of children by training clinician scientists within the field of child health. It is our vision that better researchers would improve the health of children.
We have established a training and career development program for young researchers: Grant writing, time management, coaching, mentoring, networking, etc… all skills that might be necessary to become a successful researcher are trained. I am very interested and willing to share our experiences with others in Europe.
Dr Yogen Singh is a Consultant Neonatologist and Paediatrician with Expertise in Cardiology with equal responsibilities in Neonatology and Paediatric Cardiology at Cambridge University Hospitals in the UK. He is an Associate Lecturer at the University of Cambridge and also holds an Honorary Consultant position at Great Ormond Street Hospital London.
He has special interest in neonatal haemodynamics, functional echocardiography and advanced functional echocardiography imaging. He is the lead author for the “Expert Consensus Statement on Neonatologist Performed Echocardiography (NPE): Training and Accreditation in the UK”. He is a member of the European neonatologist Performed Echocardiography Steering group, who have published European NPE guidelines. He is an educational, academic and research lead at the Paediatrician with Expertise in Cardiology Special Interest Group (PECSIG) executive committee and also a lead for the accreditation and training at NICHe (Neonatologist with Interest in Cardiology and Haemodynamics) group UK.
Yogen is a co-founder and course director at ‘Yorkshire Paediatric Echocardiography Course’ and a course director at ‘Cambridge Paediatric and Neonatal Echocardiography Course’. He has facilitated more than 20 functional echocardiography workshops / courses in UK, Europe, USA and beyond.
Please visit his website: www.dryogensingh.co.uk for further information.
As a neonatologist and developmental pediatrician I am interrested in developmental brain injury. My research looks at alteration of the developing brain with: Neuropathology, neuroimaging (MRI), functional evaluation and neuroprotection (drugs and nutritional intervention). Activities and projects in basic science research and clinical research: acute preterm brain injury, developmental brain injury in intra-uterine growth restriction. Further developmental care and its effect on brain development is part of my interrests.
Dr. Subhedar is a Consultant Neonatologist working at Liverpool Women’s Hospital. He qualified from the University of Bristol in 1988 and trained in Bristol, Liverpool and Brisbane, Australia. He was awarded an MD in 1998 for research into neonatal pulmonary hypertension and inhaled nitric oxide therapy. He has a clinical and research interest in cardiorespiratory disorders and echocardiography in neonates. He led the first randomised controlled trial of inhaled nitric oxide in preterm neonates and currently chairs the European Inhaled Nitric Oxide Registry.
Pierre Szepetowski, born 1960, MD, PhD, CNRS Director of Research (DR1), is heading the EPIPATH research team at the Mediterranean Institute of Neurobiology (INMED, INSERM U901, Aix-Marseille University). He is a honorary professor of Changsha University, China, and a member of the Administrative and of the Scientific Advisory Boards of the French League against Epilepsy (LFCE). His group has long been focusing on the relationships between various pediatric epileptic and nonepileptic pathological conditions on the one hand, and brain development and maturation on the other hand. He has coordinated multi-level studies that included human genetics, molecular and cell biology, immunohistochemistry, electrophysiology, in utero intracerebroventricular electroporation, phenotype characterization, and therapeutic assays in animal models. In the recent years his group has recently identified key epilepsy genes; notably he demonstrated the role of NMDA receptor subunit gene GRIN2A in patients and families presenting with the epilepsy-aphasia spectrum of disorders, and of the PRRT2 gene in variably associated infantile convulsions, paroxysmal dyskinesia, and hemiplegic migraine. He has also demonstrated that postnatal epileptic activity caused by in utero neuronal migration defect in the rat embryonic brain could be prevented by early and short drug administration during pregancy. He has also recently put a strong interest in the design and the validation of a rat model of cytomegalovirus infection of the developing brain, in which the brain immune system is prominently altered.
Nicole Thiele joined EFCNI in 2010 and holds the position of Vice Chair of the Executive Board of the European Foundation for the Care of Newborn Infants (EFCNI). In this function, she is involved in the overall management of the Foundation, from daily business to developing the long-term strategies, campaigning or communication tools with different key stakeholders in the maternal and newborn health arena, with the aim to improve maternal and newborn health across Europe and beyond and enhancing the collaboration between patients, healthcare professionals, researchers and other key stakeholders. Nicole developed declarations, guidelines and educational and information material targeting parents and families of preterm children, the general public and other stakeholders. She is author, co-author and co-editor of different reports and papers.
With her family experiencing the consequences of an extremely preterm birth at the beginning of modern neonatology, she is personally committed to drive forward the prevention of prematurity and particularly the philosophy of family centred, developmentally supportive care and parental inclusion in care, crucial contributors to give a baby the best chances at life and to develop to their full potential.
Bert van der Horst received his PhD in Cell Biology at the Erasmus University Rotterdam in 1993, where he studied the lysosomal enzyme sialidase. As a postdoctoral fellow at the Department of Molecular Genetics, Erasmus MC, he has generated and characterized a large panel of (conditional) animal models for DNA repair disorders, associated with skin cancer predisposition and/or premature aging (e.g. Cockayne syndrome), as well as for mammalian homologs of the repair protein photolyase (mCry1 and mCry2). Unexpectedly, the mCry genes were shown to encode indispensable components of the biological clock, a major breakthrough in the field of chronobiology. For the latter work he received a prestigious ZonMW Vici award that stood at the basis of a new research line in the Department, focusing on the molecular mechanism and biological impact of the circadian system.
By integrating running research lines on the circadian clock, genome instability and aging in a new multidisciplinary research direction, and by applying state of the art technology (i.e. conditional mouse models, clock-synchronized cultured cells, transcriptomics/next generation sequencing, in vivo imaging in cells, tissues and animals), the Chronobiology & Health research group aims at obtaining fundamental knowledge on the biological/medical impact of the circadian system. Special emphasis is on the origin and treatment of diseases (i.e. cancer, age-related disorders) including the adverse effect of chronic circadian disturbance (i.e. shift work) thereon. Recently, the group became interested in how pre- and postnatal environmental conditions may influence the programming of the circadian system and how this may impact on later life health. Ultimate goal is to translate obtained knowledge into applications to prevent or delay onset of health problems (preventive intervention) and into new clinical approaches in cancer and other drug-based therapies (personalized medicine, chronotherapy).
Dr Karen Walker is a Clinical Associate Professor with both Sydney Nursing and Sydney Medical School at the University of Sydney. She is a Clinical Research Fellow in Grace Centre for Newborn Care at the Children’s Hospital at Westmead in Sydney, a Senior Research Fellow with the Cerebral Palsy Alliance and a member of the international steering committee for the International Multi-disciplinary Prevention and Cure Team for Cerebral Palsy (IMPACT for CP). She has more than 50 publications and has presented at over 100 national and international conferences. She is the current president of the Australian College of Neonatal Nurses and Vice President of the Council of International Neonatal Nurses.
Dr Suellen Walker MBBS MMed MSc PhD FANZCA FFPMANZCA FPMRCA Dr Suellen Walker MBBS MMed MSc PhD FANZCA FFPMANZCA FPMRCA Reader and Consultant in Paediatric Anaesthesia and Pain MedicineDr Walker’s clinical practice involves inpatient and outpatient paediatric pain medicine. Her clinical and translational laboratory research relates to the developmental neurobiology of pain, developmental pharmacodynamics of analgesics, and long-term effects of neonatal pain.